C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-26.16%
↓ 60% below average
Average (6y)
-16.36%
Historical baseline
Range
High:4.95%
Low:-38.70%
CAGR
+30.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -26.16% | +32.4% |
| 2023 | -38.70% | -0.1% |
| 2022 | -38.65% | -549.4% |
| 2021 | -5.95% | -25.1% |
| 2020 | -4.76% | -196.1% |
| 2019 | 4.95% | +194.9% |
| 2018 | -5.22% | - |